252 results match your criteria Renal Oncocytoma Imaging


Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI.

Diagn Interv Radiol 2019 Jan;25(1):5-13

Department of Radiology, Dokuz Eylül University School of Medicine, İzmir, Turkey.

Purpose: We aimed to evaluate magnetic resonance imaging (MRI) features, including signal intensities, enhancement patterns and T2 signal intensity ratios to differentiate oncocytoma from chromophobe renal cell carcinoma (RCC).

Methods: This retrospective study included 17 patients with oncocytoma and 33 patients with chromophobe RCC who underwent dynamic MRI. Two radiologists independently reviewed images blinded to pathology. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5152/dir.2018.18013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339620PMC
January 2019
1 Read

A Case of Renal Oncocytoma with Renal Venous Tumor Thrombus.

Keio J Med 2018 Nov 23. Epub 2018 Nov 23.

Departments of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.

Renal oncocytoma is generally regarded as a benign renal tumor. We herein report a case of large renal oncocytoma with renal venous tumor thrombus. The patient may need to be carefully followed up because hematogenous metastasis may occur. Read More

View Article

Download full-text PDF

Source
https://www.jstage.jst.go.jp/article/kjm/advpub/0/advpub_201
Publisher Site
http://dx.doi.org/10.2302/kjm.2017-0012-CRDOI Listing
November 2018
1 Read

Imaging of Solid Renal Masses.

Urol Clin North Am 2018 Aug 15;45(3):311-330. Epub 2018 Jun 15.

Department of Radiology; UT Southwestern Medical Center, 2201 Inwood Road, Suite 210, Dallas, TX 75390, USA. Electronic address:

The increase in serendipitous detection of solid renal masses on imaging has not resulted in a reduction in mortality from renal cell carcinoma. Consequently, efforts for improved lesion characterization have been pursued and incorporated into management algorithms for distinguishing clinically significant tumors from those with favorable histology or benign conditions. Although diagnostic imaging strategies have evolved for optimized lesion detection, distinction between benign tumors and both indolent and aggressive malignant neoplasms remain an important diagnostic challenge. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2018.03.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057157PMC
August 2018
15 Reads

Incidentally detected ectopic thyroid in juxta cardiac location-Imaging and pathology.

Radiol Case Rep 2018 Aug 9;13(4):909-913. Epub 2018 Jul 9.

Department of Radiology, University of Alabama in Birmingham, Birmingham, AL, USA.

Ectopic thyroid gland is a developmental anomaly that results from the arrest of thyroid tissue along its path of descent from the floor of mouth to the pre tracheal position in the lower neck. It is typically found along the thyroglossal duct with the base of the tongue being the most common site. Apart from mediastinal extension of goiter, the incidence of true intrathoracic ectopic thyroid tissue is rare. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19300433183008
Publisher Site
http://dx.doi.org/10.1016/j.radcr.2018.06.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043872PMC
August 2018
10 Reads

Oncocytoma managed by active surveillance in a transplant allograft kidney: a case report.

World J Surg Oncol 2018 Jul 2;16(1):123. Epub 2018 Jul 2.

Department for the Treatment and Study of Abdominal Diseases and Abdominal Transplantation, IRCCS-ISMETT (Istituto di Ricovero e Cura a Carattere Scientifico - Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), UPMC (University of Pittsburgh Medical Center) Italy, Via E. Tricomi 5, 90127, Palermo, Italy.

Background: The ethical implications of the utilization of kidneys with solid renal masses (SRMs) in transplantation are the subject of lively debate in the transplantation community and beyond. One of such implications is that as the life expectancy of renal transplant patients improve, the prevalence of SRMs in donors is likely to increase. We report a case of an oncocytoma in a renal allograft complicating a deceased-donor kidney transplant. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12957-018-1426-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029171PMC
July 2018
1.200 Impact Factor

Renal oncocytoma in a kidney transplant patient: the imaging features on contrast-enhanced ultrasonography (CEUS): a case report.

J Bras Nefrol 2018 Jan-Mar;40(1):86-90. Epub 2018 Apr 19.

Hospital Universitário Pedro Ernesto, Vila Isabel, Rio de Janeiro, RJ, Brasil.

Renal oncocytoma is an infrequently reported renal neoplasm, often asymptomatic, which usually behaves as a benign entity and is identified accidentally on radiological imaging. Transplant patients under long-term immunosuppressive drugs have a high prevalence of cancers, such as skin cancers, lymphoproliferative disorders, and renal carcinomas. We present a case report of an asymptomatic renal oncocytoma in a kidney transplant recipient presenting persistent hematuria. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/1678-4685-JBN-3787DOI Listing
January 2019
1 Read

A back-to-back tumor composed of papillary renal cell carcinoma and oncocytoma treated by laparoscopic partial nephrectomy: a case report.

J Med Case Rep 2018 May 21;12(1):146. Epub 2018 May 21.

Departments of Urology and pathology, Kosin University Gospel Hospital, Kosin University College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan, 49267, South Korea.

Background: Renal oncocytoma is the most common benign renal tumor, and papillary renal cell carcinoma is the second most common histologic subtype of renal cell carcinoma. Renal tumors containing different components such as papillary renal cell carcinoma and oncocytoma are extremely rare.

Case Presentation: A renal mass was incidentally detected in a 52-year-old Korean woman, and a computed tomographic scan showed a 32-mm multicystic mass with some calcifications in the lower pole of the right kidney. Read More

View Article

Download full-text PDF

Source
https://jmedicalcasereports.biomedcentral.com/articles/10.11
Publisher Site
http://dx.doi.org/10.1186/s13256-018-1662-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961515PMC
May 2018
3 Reads

Renal hybrid oncocytic/chromophobe tumor associated with multiple schwannomas: Case report and literature review.

Medicine (Baltimore) 2017 Dec;96(48):e8939

Department of Urology.

Rationale: Renal hybrid oncocytic/chromophobe tumors (HOCTs) are benign tumors containing a mixture of cells with features of chromophobe renal cell carcinoma (CHRCC) and renal oncocytoma (RO). Sporadic HOCT, which means HOCT occurs in patients without Birt-Hogg-Dubé syndrome (BHDS) or renal oncocytosis, is extremely rare. In this article, we would report a new case of a patient with both sporadic HOCT and multiple Schwannomas, which is even rarer than simplex sporadic HOCT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000008939DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728788PMC
December 2017
9 Reads

Quantitative Contour Analysis as an Image-based Discriminator Between Benign and Malignant Renal Tumors.

Urology 2018 Apr 2;114:121-127. Epub 2018 Jan 2.

Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Objective: To investigate whether morphologic analysis can differentiate between benign and malignant renal tumors on clinically acquired imaging.

Materials And Methods: Between 2009 and 2014, 3-dimensional tumor volumes were manually segmented from contrast-enhanced computerized tomography (CT) images from 150 patients with predominantly solid, nonmacroscopic fat-containing renal tumors: 100 renal cell carcinomas and 50 benign lesions (eg, oncocytoma and lipid-poor angiomyolipoma). Tessellated 3-dimensional tumor models were created from segmented voxels using MATLAB code. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2017.12.018DOI Listing
April 2018
14 Reads

Oncocytoma: A Differential Consideration for an Incidentally Detected FDG-Avid Renal Mass on PET/CT.

J Radiol Case Rep 2017 May 31;11(5):27-33. Epub 2017 May 31.

Department of Radiology, UF Health Shands Hospital, Gainesville, FL, USA.

Renal oncocytoma is a benign renal neoplasm that is often discovered incidentally and closely mimics renal cell carcinoma on common imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI). Due to the inability to reliably distinguish between these benign and malignant lesions with imaging, both are typically treated as if they are malignant. Hypermetabolic activity of renal oncocytomas is not frequently encountered because positron emission tomography (PET) is not a standard modality for imaging primary renal tumors. Read More

View Article

Download full-text PDF

Source
http://www.radiologycases.com/index.php/radiologycases/artic
Publisher Site
http://dx.doi.org/10.3941/jrcr.v11i5.3117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743137PMC
May 2017
6 Reads

Use of quantitative SPECT/CT reconstruction in Tc-sestamibi imaging of patients with renal masses.

Ann Nucl Med 2018 Feb 6;32(2):87-93. Epub 2017 Dec 6.

The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N. Caroline St., Baltimore, MD, 21287, USA.

Objective: Technetium-99m (Tc)-sestamibi single-photon emission computed tomography/computed tomography (SPECT/CT) has previously been shown to allow for the accurate differentiation of benign renal oncocytomas and hybrid oncocytic/chromophobe tumors (HOCTs) apart from other malignant renal tumor histologies, with oncocytomas/HOCTs showing high uptake and renal cell carcinoma (RCC) showing low uptake based on uptake ratios from non-quantitative single-photon emission computed tomography (SPECT) reconstructions. However, in this study, several tumors fell close to the uptake ratio cutoff, likely due to limitations in conventional SPECT/CT reconstruction methods. We hypothesized that application of quantitative SPECT/CT (QSPECT) reconstruction methods developed by our group would provide more robust separation of hot and cold lesions, serving as an imaging framework on which quantitative biomarkers can be validated for evaluation of renal masses with Tc-sestamibi. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12149-017-1222-zDOI Listing
February 2018
8 Reads

Use of Tc-sestamibi Single-photon Emission Computed Tomography / X-ray Computed Tomography in the Diagnosis of Hybrid Oncocytic / Chromophobe Tumor in a Pediatric Patient.

Urology 2018 Mar 23;113:206-208. Epub 2017 Nov 23.

Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. Electronic address:

The differential diagnosis of solid renal neoplasms in adolescence includes aggressive malignancy and indolent oncocytic tumors, which are typically indistinguishable using conventional imaging. We report the use of Tc-sestamibi single-photon emission computed tomography / x-ray computed tomography (SPECT/CT) in characterizing enhancing renal neoplasms in a pediatric patient. Genetic testing suggested a hereditary syndrome associated with aggressive malignancy, whereas renal mass biopsy suggested an oncocytic tumor. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2017.11.015DOI Listing
March 2018
7 Reads

Modern Pathologic Diagnosis of Renal Oncocytoma.

J Kidney Cancer VHL 2017 9;4(4):1-12. Epub 2017 Oct 9.

Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.

Oncocytoma is a well-defined benign renal tumor, with classic gross and histologic features, including a tan or mahogany-colored mass with central scar, microscopic nested architecture, bland cytology, and round, regular nuclei with prominent central nucleoli. As a result of variations in this classic appearance, difficulty in standardizing diagnostic criteria, and entities that mimic oncocytoma, such as eosinophilic variant chromophobe renal cell carcinoma and succinate dehydrogenase-deficient renal cell carcinoma, pathologic diagnosis remains a challenge. This review addresses the current state of pathologic diagnosis of oncocytoma, with emphasis on modern diagnostic markers, areas of controversy, and emerging techniques for less invasive diagnosis, including renal mass biopsy and advanced imaging. Read More

View Article

Download full-text PDF

Source
https://jkcvhl.com/index.php/jkcvhl/article/view/96
Publisher Site
http://dx.doi.org/10.15586/jkcvhl.2017.96DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634396PMC
October 2017
6 Reads

Characterizing Indeterminate Renal Masses with Molecular Imaging: the Role of Tc-MIBI SPECT/CT.

Curr Urol Rep 2017 Sep 12;18(11):86. Epub 2017 Sep 12.

Department of Radiology, University of Alabama at Birmingham School of Medicine, 619 19th Street South, JT N325, Birmingham, AL, 35249-6830, USA.

Purpose Of Review: The majority of enhancing renal masses cannot be characterized through imaging as malignant or benign; however, such characterization could save patients from unnecessary surgery and/or biopsy and associated morbidity. Herein, we review the recent literature on the emerging use of Tc-MIBI SPECT/CT in preoperative differentiation of enhancing renal masses.

Recent Findings: Recent reports have shown that Tc-MIBI SPECT/CT imaging can differentiate mitochondrial-rich, benign, or indolent renal masses from renal cell carcinoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11934-017-0737-0DOI Listing
September 2017
9 Reads

Value of triphasic MDCT in the differentiation of small renal cell carcinoma and oncocytoma.

Urologia 2017 Oct 11;84(4):244-250. Epub 2017 Aug 11.

Department of Urology, University of Modena and Reggio Emilia, Modena - Italy.

Introduction: Although differentiation between benign and malignant small renal tumors (≤4 cm) is still difficult, it is a demand for decision making and determining the treatment strategy. Our aim is to evaluate the role of multidetector row computed tomography (MDCT) in the differentiation of small renal clear cell carcinoma (RCC) and renal oncocytoma (RO).

Methods: We reviewed triphasic computed tomographic (CT) scans performed in 43 patients diagnosed with RCC (n = 23) and RO (n = 21). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/uj.5000256DOI Listing
October 2017
49 Reads

Liver Metastases From Renal Oncocytoma With Vascular Extension.

Appl Immunohistochem Mol Morphol 2017 Jul 4. Epub 2017 Jul 4.

*Urology Clinic Departments of †Diagnostics and Public Health ‡General Surgery and Odontoiatrics #Medicine, Renal Unit, University and Hospital Trust, Verona ∥Department of Specialised, Experimental and Diagnostic Medicine, Sant'Orsola-Malpighi University Hospital, Bologna ¶Anatomic Pathology, Pederzoli Hospital, Peschiera Del Garda, Italy §Department of Pathology, Faculty of Medicine in Plzen, Charles University, Pilsen, Czech Republic.

The 2016 World Health Organization Renal Tumor Classification defines renal oncocytoma (RO) as a benign epithelial tumor; however, malignant histopathologic features have been documented. Rare cases with metastases have been reported. We describe the case of a 62-year-old woman who was referred to the Urology Clinic for a routine work-up. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00129039-900000000-9893
Publisher Site
http://dx.doi.org/10.1097/PAI.0000000000000490DOI Listing
July 2017
33 Reads

Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.

Eur Radiol 2017 Dec 19;27(12):4913-4922. Epub 2017 Jun 19.

Department of Radiology, Chinese PLA General Hospital, Fuxing Road 28, Box 100853, Beijing, China.

Objectives: To compare the performance of diffusion-weighted imaging (DWI) with that of contrast-enhanced MRI in differentiating renal oncocytomas from chromophobe renal cell carcinomas (RCCs).

Methods: We recruited 48 patients with histopathologically confirmed renal oncocytomas (n=16) and chromophobe RCCs (n=32). All patients underwent preoperative DWI and contrast-enhanced MRI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-017-4906-9DOI Listing
December 2017
56 Reads

Remote Development of Tumor-to-Tumor Metastasis of Breast Adenocarcinoma in a Renal Oncocytoma.

Urology 2017 Sep 24;107:e1-e2. Epub 2017 May 24.

Department of Urology, University of Virginia Health System, Charlottesville, VA.

Tumor-to-tumor metastasis (TTM) is a rare phenomenon where a focus of distinct metastatic disease is discovered with a second primary tumor. Although renal cell carcinoma is the most frequent recipient of metastatic tumor cells, oncocytomas have also previously been described. We present the case of a patient with incidentally detected mammary adenocarcinoma within an oncocytoma 16 years following primary treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2017.05.022DOI Listing
September 2017
6 Reads

Does Computed Tomography Still Have Limitations to Distinguish Benign from Malignant Renal Tumors for Radiologists?

Urol Int 2017 8;99(2):229-236. Epub 2017 Mar 8.

USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Objectives: To evaluate the current accuracy of CT for diagnosing benign renal tumors.

Materials And Methods: We retrospectively reviewed 905 patients who underwent preoperative CT followed by surgical resection. The final pathology was benign in 156 patients (17%). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000460303DOI Listing
June 2018
12 Reads
1 Citation
1.151 Impact Factor

Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.

Abdom Radiol (NY) 2017 06;42(6):1734-1743

Department of Radiology, Massachusetts General Hospital [MGH], Harvard Medical School, Boston, MA, 02114, USA.

Objective: To evaluate whether the Aorta-Lesion-Attenuation-Difference on contrast-enhanced CT can aid in the differentiation of malignant and benign oncocytic renal neoplasms.

Materials And Methods: Two independent cohorts-an initial (biopsy) dataset and a validation (surgical) dataset-with oncocytomas and chromophobe renal cell carcinomas (chRCC) were included in this IRB-approved retrospective study. A region of interest was placed on the renal mass and abdominal aorta on the same CT image slice to calculate an Aorta-Lesion-Attenuation-Difference (ALAD). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-017-1061-3DOI Listing
June 2017
13 Reads

Giant renal oncocytoma with classic stellate scar.

BMJ Case Rep 2017 Jan 27;2017. Epub 2017 Jan 27.

Department of Urology, MedStar Georgetown University Hospital, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2016-218944DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278321PMC
January 2017
5 Reads

Imaging of Solid Renal Masses.

Radiol Clin North Am 2017 Mar 12;55(2):243-258. Epub 2016 Dec 12.

Department of Radiology and Advanced Imaging Research Center, UT Southwestern Medical Center, Harry Hines 5323, 2201 Inwood Road, Dallas, TX 75390, USA. Electronic address:

Detection of solid renal masses has increased, although it has not resulted in significant mortality reduction from renal cell carcinoma. Efforts for improved lesion characterization have been pursued and incorporated in management algorithms, in order to distinguish clinically significant tumors from favorable or benign conditions. Concurrently, imaging methods have produced evidence supporting their role as useful tools not only in lesion detection but also characterization. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rcl.2016.10.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607740PMC
March 2017
8 Reads

Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.

AJR Am J Roentgenol 2017 Apr 26;208(4):812-819. Epub 2017 Jan 26.

1 Department of Radiology, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Ste 1638, Los Angeles, CA 90095-7437.

Objective: The objective of our study was to investigate the performance of relative enhancement on multiphasic MRI to differentiate clear cell renal cell carcinoma (RCC) from other RCC subtypes (papillary and chromophobe) and oncocytoma.

Materials And Methods: For this study, we derived a cohort of 34 clear cell RCCs, nine oncocytomas, 12 papillary RCCs, and 10 chromophobe RCCs with a preoperative multiphasic dynamic contrast-enhanced MRI study with up to four phases (i.e. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.16.17152DOI Listing
April 2017
13 Reads

Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?

AJR Am J Roentgenol 2017 Feb 13;208(2):343-350. Epub 2016 Dec 13.

1 Department of Radiology, Pellegrin Hospital, Pl Amélie Raba Léon, 33076 Bordeaux, France.

Objective: The purpose of this study was to retrospectively evaluate the diagnostic accuracy of multiparametric MRI to differentiate oncocytoma from chromophobe renal cell carcinoma (RCC).

Materials And Methods: In this retrospective study, 26 histologically confirmed oncocytomas and 16 chromophobe RCCs that underwent full MRI examination were identified in 42 patients (25 men and 17 women) over a 6-year period. Demographic data were recorded. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.16.16832DOI Listing
February 2017
13 Reads

Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.

Int Urol Nephrol 2017 Feb 16;49(2):215-224. Epub 2016 Nov 16.

Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho tr 1946/1, 612 42, Brno, Czech Republic.

Background: Renal cell carcinoma (RCC) represents the most common malignant epithelial neoplasm of the kidney. Accurate assessment of the renal masses, defining the histologic subtype and the grade of differentiation of the tumor, is vital to ensure an adequate case management as well as for staging and prognosis. Recently, diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) tends to be increasingly appealing for the clinicians as an imaging procedure of choice for the diagnosis and staging of the RCC, which is predetermined by several advantages over CT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-016-1460-3DOI Listing
February 2017
18 Reads

Active surveillance is suitable for intermediate term follow-up of renal oncocytoma diagnosed by percutaneous core biopsy.

BJU Int 2016 Oct 26;118 Suppl 3:30-34. Epub 2016 Jul 26.

Uropath Pty Ltd, West Leederville, WA, Australia.

Objectives: To evaluate the intermediate outcome of conservative management in patients with biopsy-proven oncocytoma.

Patients And Methods: Patients with oncocytoma diagnosed on percutaneous core biopsy between January 2000 to December 2014 were identified from the renal biopsy database of a large specialist urologic pathology laboratory. After review of patient clinical records, the study cohort comprised only of patients enrolled in active surveillance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13538DOI Listing
October 2016
5 Reads

Surgical Treatment of Tumors Involving Kidneys With Fusion Anomalies: A Contemporary Series.

Urology 2016 Dec 3;98:97-102. Epub 2016 Aug 3.

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

Objective: To report a contemporary series of surgically treated patients with tumors involving kidneys with fusion anomalies.

Materials And Methods: We retrospectively reviewed the medical records of all 10 patients treated at a single tertiary care institution for tumors involving kidneys with fusion anomalies between the years 2000 and 2015. One patient, diagnosed with lymphoma, did not undergo surgical treatment and was therefore excluded. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2016.07.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125232PMC
December 2016
7 Reads

Can the multiphasic computed tomography be useful in the clinical management of small renal masses?

Acta Radiol 2017 May 30;58(5):625-633. Epub 2016 Sep 30.

1 Department of Radiology, Sant'Orsola-Malpighi Hospital, Bologna, Italy.

Background Small renal masses (SRMs; ≤4 cm) represent a challenging issue. Computed tomography (CT) is widely used for investigating renal tumors even if its ability to differentiate among the different subtypes has not yet been definitively established. Purpose To assess the potential role of the morphological features and angiodynamic behavior on multiphasic CT in the preoperative evaluation of SRMs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0284185116663042DOI Listing
May 2017
6 Reads

Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma.

Abdom Radiol (NY) 2017 02;42(2):552-560

Keck School of Medicine, University of Southern California, 1500 San Pablo St, 2nd Floor Imaging, Los Angeles, CA, 90033, USA.

Purpose: The purpose of this study was to compare whole-lesion (WL) enhancement parameters to single region of interest (ROI)-based enhancement in discriminating clear cell renal cell carcinoma (ccRCC) from renal oncocytoma.

Materials And Methods: In this IRB-approved retrospective study, the surgical database was queried to derive a cohort of 94 postnephrectomy patients with ccRCC or oncocytoma (68 ccRCC, 26 oncocytoma), who underwent preoperative multiphase contrast-enhanced computed tomography (CECT) between June 2009 and August 2013. CT acquisitions were transferred to a three-dimensional workstation, and WL ROIs were manually segmented. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-016-0891-8DOI Listing
February 2017
26 Reads

Oncocytic Neoplasm on Renal Mass Biopsy: A Diagnostic Conundrum.

Oncology (Williston Park) 2016 May;30(5):426-35

View Article

Download full-text PDF

Source
May 2016
5 Reads

Computed Tomography Appearance of Renal Hybrid Oncocytic/Chromophobe Tumors.

J Comput Assist Tomogr 2016 Jul-Aug;40(4):513-6

From the *Russell H. Morgan Department of Radiology and Radiological Science and †The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD.

Objective: A series of renal hybrid oncocytic/chromophobe tumors (HOCTs) was retrospectively assessed for morphologic features and enhancement characteristics by computed tomography (CT).

Materials (subjects) And Methods: Nine patients with pathologically proven HOCTs were identified. These patients harbored a total of 12 lesions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0000000000000409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949112PMC
January 2017
6 Reads

Differential radiologic characteristics of renal tumours on multiphasic computed tomography.

Singapore Med J 2017 May 19;58(5):262-266. Epub 2016 Apr 19.

Division of Medical Oncology, National Cancer Centre Singapore, Singapore.

Introduction: This study analysed the tumour attenuation characteristics of different subtypes of renal cell carcinomas (RCCs), including clear cell RCC (ccRCC), papillary RCC (pRCC), mixed RCC, chromophobe RCC (chRCC) and oncocytoma.

Methods: We randomly selected 100 RCC cases that underwent nephrectomy between 2004 and 2012 from a collaborative database. Of these cases, 36 were excluded due to the absence of available imaging. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11622/smedj.2016081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435845PMC
May 2017
11 Reads
0.634 Impact Factor

[The diagnostic and therapeutic challenges of bilateral renal oncocytosis : Illustrative case presentations and a review of the literature].

Urologe A 2016 Jul;55(7):941-8

Urologische Klinik, St. Elisabeth Klinikum Straubing, St. Elisabeth-Str. 23, 94315, Straubing, Deutschland.

Bilateral oncocytosis along with multiple tumours in both kidneys represents a very rare pathology that is accompanied by diagnostic and therapeutic challenges. We report the case of a 60-year old male patient who underwent computer tomography with incidental detection of multiple bilateral and contrast enhancing renal tumours of different size. Subsequently the patient underwent nephron-sparing tumor resection, first on the right side and 4 weeks later on the left side. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00120-016-0058-9DOI Listing
July 2016
3 Reads

[Managing focal incidental renal lesions].

Radiologia 2016 Mar-Apr;58(2):81-7. Epub 2015 Dec 24.

Servicio de Radiología, Hospital Clínic de Barcelona, Barcelona, España.

Incidental renal lesions are relatively common in daily radiological practice. It is important to know the different diagnostic possibilities for incidentally detected lesions, depending on whether they are cystic or solid. The management of cystic lesions is guided by the Bosniak classification. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rx.2015.10.008DOI Listing
September 2017
2 Reads

[Case study of renal oncocytoma at the Kati hospital].

Mali Med 2016 ;31(3):45-48

Service de radiologie & de médecine nucléaire CHU du Point « G » Bamako (Mali).

Renal oncocytoma is a rare benign tumor of the kidney. This benign tumor of epithelial origin represents 5% of renal tumors. Preoperative diagnosis is difficult. Read More

View Article

Download full-text PDF

Source
January 2016

Dilemmas in diagnosis and natural history of renal oncocytoma and implications for management.

Can Urol Assoc J 2015 Sep-Oct;9(9-10):E709-12. Epub 2015 Oct 13.

Department of Urology, Adelaide and Meath hospital, Tallaght, Dublin, Ireland.

Introduction: Oncocytomas have traditionally been treated with surgical excision; however, their excellent long-term prognosis has popularized conservative and minimally invasive ablative techniques. We evaluated the evolving management and natural history of renal oncocytomas and investigated the relationship between radiological and histopathological diagnosis.

Methods: We performed a 17-year retrospective cohort study on all patients with a confirmed histopathological diagnosis of renal oncocytoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.3144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662443PMC
December 2015
3 Reads

Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.

AJR Am J Roentgenol 2015 Nov;205(5):999-1007

1 Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

Objective: The purpose of this study was to evaluate whether small (< 4 cm) oncocytomas can be differentiated from renal cell carcinomas (RCCs) on biphasic contrast-enhanced CT.

Materials And Methods: Forty-three patients with 53 oncocytomas and 123 patients with 128 RCCs (24 papillary subtype and 104 clear cell and other subtypes) who underwent biphasic contrast-enhanced CT were included in the study. Patient demographics and CT tumor characteristics were evaluated in each case. Read More

View Article

Download full-text PDF

Source
http://www.ajronline.org/doi/10.2214/AJR.14.13966
Publisher Site
http://dx.doi.org/10.2214/AJR.14.13966DOI Listing
November 2015
10 Reads

Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.

Korean J Urol 2015 Oct 6;56(10):695-702. Epub 2015 Oct 6.

Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.

Purpose: To investigate and distinguish the computed tomography (CT) characteristics of chromophobe renal cell carcinoma (chRCC) and renal oncocytoma.

Materials And Methods: Fifty-one patients with renal oncocytoma and 120 patients with chRCC, diagnosed by surgery between November 2005 and June 2015, were studied retrospectively. Two observers, who were urologists and unaware of the pathological results, reviewed the preoperative CT images. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4111/kju.2015.56.10.695DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610896PMC
October 2015
17 Reads

Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.

Eur Urol 2016 Mar 18;69(3):413-6. Epub 2015 Sep 18.

The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:

Unlabelled: Nuclear imaging offers a potential noninvasive means of determining the histology of renal tumors. The aim of this study was to evaluate the accuracy of technetium-99m ((99m)Tc)-sestamibi single-photon emission computed tomography/x-ray computed tomography (SPECT/CT) for the differentiation of oncocytomas and hybrid oncocytic/chromophobe tumors (HOCTs) from other renal tumor histologies. In total, 50 patients with a solid clinical T1 renal mass were imaged with (99m)Tc-sestamibi SPECT/CT prior to surgical resection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.08.056DOI Listing
March 2016
51 Reads

Intraoperative and surgical specimen (ex vivo) ultrasound in the assessment of margins at partial nephrectomy.

Int Urol Nephrol 2015 Oct 13;47(10):1665-9. Epub 2015 Aug 13.

Department of Urology, James Cook University Hospital, Marton Road, Middlesbrough, TS43GE, UK.

Purpose: To correlate the accuracy of intraoperative and surgical specimen (ex vivo) ultrasound (US) with pathological margin status at partial nephrectomy.

Materials And Methods: Patients undergoing partial nephrectomy for T1 renal tumours in the period May 2010-January 2014 at a single institution who had intraoperative specimen US were included. PN was performed by standardised technique with intraoperative tumour localisation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-015-1083-0DOI Listing
October 2015
3 Reads

Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma.

Acta Radiol 2016 Apr 13;57(4):500-6. Epub 2015 May 13.

Department of Medical Imaging, Subei People's Hospital, Medical School of Yangzhou University, Yangzhou, PR China.

Background: Renal oncocytoma (RO) and chromophobe renal cell carcinoma (ChRCC) share histologic and some imaging features.

Purpose: To investigate the multidetector computed tomography (MDCT) characteristics of these two tumor types.

Material And Methods: Fifty-six patients with RO and 54 patients with ChRCC were studied retrospectively. Read More

View Article

Download full-text PDF

Source
http://acr.sagepub.com/content/early/2015/05/13/028418511558
Web Search
http://acr.sagepub.com/lookup/doi/10.1177/0284185115585035
Publisher Site
http://dx.doi.org/10.1177/0284185115585035DOI Listing
April 2016
6 Reads

Diffusion-weighted imaging using 3.0 T MRI as a possible biomarker of renal tumors.

Anticancer Res 2015 Apr;35(4):2351-7

Department of Radiology, Medical School and Teaching Hospital Pilsen, Charles University in Prague, Pilsen, Czech Republic Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.

Background/aim: Diffusion-weighted imaging (DWI) allows for differentiation of benign from malignant tumors, histological tumor types and their grade. The aim of the study was to evaluate the capabilities of DWI using 3 Tesla Magnetic resonance imaging (3T MRI) in the preoperative assessment of renal tumors.

Patients And Methods: This retrospective study included 143 tumors in 139 patients (130 malignant tumors and 13 benign tumors) that were examined using DWI with b values of 50, 400 and 800 s/mm(2). Read More

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/35/4/2351.full.pdf
Web Search
April 2015
6 Reads

[Renal oncocytosis is a diagnostic challenge].

Ugeskr Laeger 2015 01;177(2A):122-3

Radiologisk Afdeling, Holstebro Sygehus, Lægårdvej 12 C, 7500 Holstebro.

Renal oncocytosis is a rare variant of renal oncocytoma with multiple, often bilateral oncocytomas. This case report discusses radiological and pathological aspects of renal oncocytoma and oncocytosis. Read More

View Article

Download full-text PDF

Source
January 2015
2 Reads

Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma.

Clin Nucl Med 2015 Apr;40(4):309-13

From the *The Russell H. Morgan Department of Radiology and Radiological Science, †The James Buchanan Brady Urological Institute and Department of Urology, and ‡Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD; and §Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany.

Purpose: The differentiation of oncocytoma from renal cell carcinoma (RCC) remains a challenge with currently available cross-sectional imaging techniques. As a result, a large number of patients harboring a benign oncocytoma undergo unnecessary surgical resection. In this study, we explored the utility of 99mTc-MIBI SPECT/CT for the differentiation of these tumors based on the hypothesis that the large number of mitochondria in oncocytomas would lead to increased 99mTc-MIBI uptake. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000670DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358706PMC
April 2015
14 Reads

Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.

Chin Med J (Engl) 2015 Jan;128(2):175-9

Department of Radiology, Beijing Union Hospital, Beijing 100730, China.

Background: The difference between renal oncocytomas (RO) and renal clear cell carcinomas (RCCs) presents the greatest diagnostic challenge. The aim of this study was to retrospectively determine if RO and RCCs could be differentiated on computed tomography (CT) images on the basis of their enhancement patterns with a new enhancement correcting method.

Methods: Forty-six patients with a solitary renal mass who underwent total or partial nephrectomy were included in this study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0366-6999.149190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837834PMC
January 2015
33 Reads

Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.

Nat Genet 2015 Jan 17;47(1):13-21. Epub 2014 Nov 17.

Molecular Biology Department, Genentech, Inc., South San Francisco, California, USA.

To further understand the molecular distinctions between kidney cancer subtypes, we analyzed exome, transcriptome and copy number alteration data from 167 primary human tumors that included renal oncocytomas and non-clear cell renal cell carcinomas (nccRCCs), consisting of papillary (pRCC), chromophobe (chRCC) and translocation (tRCC) subtypes. We identified ten significantly mutated genes in pRCC, including MET, NF2, SLC5A3, PNKD and CPQ. MET mutations occurred in 15% (10/65) of pRCC samples and included previously unreported recurrent activating mutations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3146DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489427PMC
January 2015
28 Reads
50 Citations
29.352 Impact Factor

Percutaneous renal tumour biopsy.

Histopathology 2014 Sep;65(3):295-308

Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, Wellington, New Zealand.

The use of percutaneous renal tumour biopsy (RTB) as a diagnostic tool for the histological characterization of renal masses has increased dramatically within the last 30 years. This increased utilization has paralleled advances in imaging techniques and an evolving knowledge of the clinical value of nephron sparing surgery. Improved biopsy techniques using image guidance, coupled with the use of smaller gauge needles has led to a decrease in complication rates. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12495DOI Listing
September 2014
2 Reads

Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI).

Eur Radiol 2014 Nov 17;24(11):2787-94. Epub 2014 Jul 17.

The Ottawa Hospital, Department of Medical Imaging, The University of Ottawa, 1053 Carling Avenue, Ottawa, Ontario, Canada, K1Y 4E9,

Objectives: Segmental enhancement inversion (SEI) is a controversial imaging finding reportedly specific for the diagnosis of renal oncocytoma. The purpose of this study was to re-evaluate SEI using biphasic CT and multiphase MRI.

Methods: With research ethics board approval, a retrospective analysis of patients with resection or biopsy of oncocytoma or chromophobe renal cell carcinoma (Ch-RCC) between 2008-2012 was performed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-014-3310-yDOI Listing
November 2014
14 Reads

[Value of real-time contrast-enhanced ultrasound in diagnosis of renal solid renal lesions].

Nan Fang Yi Ke Da Xue Xue Bao 2014 Jun;34(6):890-5

Department of Interventional Ultrasound, General Hospital of PLA, Beijing 100853, China.E-mail:

Objective: To investigate the value of real-time contrast-enhanced ultrasound (CEUS) in the diagnosis and differential diagnosis of renal solid renal lesions (RSLs).

Methods: We retrospectively analyzed 140 cases of 152 RSLs with a mean diameter 3.1∓1. Read More

View Article

Download full-text PDF

Source
June 2014
31 Reads

An interesting case of F-18 fluorodeoxyglucose positron emission tomography avid renal oncocytoma.

ANZ J Surg 2016 Jan-Feb;86(1-2):99-100. Epub 2014 Apr 16.

Urology, Royal Newcastle Centre, Newcastle, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ans.12637DOI Listing
December 2016
4 Reads